Ecthyma gangrenosum in a 3-year-old boy post-heart transplantation.
Pseudomonas aeruginosa
ecthyma gangrenosum
heart transplant recipient
rituximab
Journal
Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
15
03
2019
revised:
25
05
2019
accepted:
09
06
2019
pubmed:
20
6
2019
medline:
18
12
2019
entrez:
20
6
2019
Statut:
ppublish
Résumé
Ecthyma gangrenosum (EG) is a serious bacterial infection in immunocompromised patients. EG in transplant recipients is rarely reported and may go unrecognized, which may delay initiation of appropriate treatment. We report a case of EG in a pediatric heart transplant recipient who was treated successfully with antibiotics and surgical debridement.
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13131Subventions
Organisme : National Center for Child Health and Development
ID : 30E-1
Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Vaiman M, Lazarovitch T, Heller L, Lotan G. Ecthyma gangrenosum and ecthyma-like lesions: review article. Eur J Clin Microbiol Infect Dis. 2015;34(4):633-639.
Khalil BA, Baillie CT, Kenny SE, et al. Surgical strategies in the management of ecthyma gangrenosumin paediatric oncology patients. Pediatr Surg Int. 2008;24(7):793-797.
Rostad CA, Wehrheim K, Kirklin JK, et al. Bacterial infections after pediatric heart transplantation: epidemiology, risk factors and outcomes. J Heart Lung Transplant. 2017;36(9):996-1003.
Hizli Ş, Işikay S, Arikan Ç. Ecthyma gangrenosum in an infant after liver transplantation. Pediatr Int. 2016;58(9):950-952.
Korte A, Vos JM. Ecthyma gangrenosum. N Engl J Med. 2017;377(23):e32.
Molgó MN, Arriagada CE, Salomone CB, et al. Skin necrosis: report of eleven cases. Rev Med Chil. 2014;142(1):118-124.
Pulido J, McMahon P, Treat JR, Gunselman J, Tasian GE, Tasian SK. Labial ecthyma gangrenosum in an immunocompromised infant with leukemia: heightening awareness for the urologist. Urology. 2012;80(6):1366-1368.
Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis. 2011;15(1):2-16.
Wolach O, Bairey O, Lahav M. Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine (Baltimore). 2010;89(5):308-318.
Monaco WE, Jones JD, Rigby WF. Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literature. Clin Rheumatol. 2016;35(10):2457-2462.
Martínez-Longoria CA, Rosales-Solis GM, Ocampo-Garza J, Guerrero-González GA, Ocampo-Candiani J. Ecthyma gangrenosum: a report of eight cases. An Bras Dermatol. 2017;92(5):698-700.
Uludokumacı S, İnanç Balkan İ, Mete B, Özaras R, Saltoğlu N, Soysal T. Ecthyma gangrenosum-like lesions in a febrile neutropenic patient with simultaneous pseudomonas sepsis and disseminated Fusariosis. Turk J Haematol. 2013;30(3):321-324.